廣東明珠(600382.SH):控股股東質押的6016.2683萬股延期購回
格隆匯3月17日丨廣東明珠(600382.SH)公佈,公司於2020年3月17日收到公司控股股東深圳金信安《關於告知股票質押式回購交易延期購回的函》。
因深圳金信安經營需要,2020年3月16日,深圳金信安將其質押給中泰證券(上海)資產有限公司的無限售條件流通股6016.2683萬股辦理了股票質押式回購交易延期購回的業務,質押期限延期至2020年09月16日。
公司控股股東深圳市金信安投資有限公司(“深圳金信安”)持有公司股份數量約1.49億股,佔公司總股本比例的24.55%;深圳金信安累計質押股份數量約1.3566億股,佔其持股數量比例的91.05%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.